Active efflux across the blood-brain barrier: role of the solute carrier family.
about
Review of Scientific Evidence of Medicinal Convoy Plants in Traditional Persian MedicineBlood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in strokeTransporters at CNS barrier sites: obstacles or opportunities for drug delivery?Blood brain barrier: a challenge for effectual therapy of brain tumorsBarrier mechanisms in the Drosophila blood-brain barrierTargeting transporters: promoting blood-brain barrier repair in response to oxidative stress injuryLack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy.Molecular and cellular characterization of ABCG2 in the prostateSelect cyclopentenone prostaglandins trigger glutathione efflux and the role of ABCG2 transportIn vitro and in vivo investigation of dexibuprofen derivatives for CNS delivery.Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?Drug delivery across the blood-brain barrier: why is it difficult? how to measure and improve it?A proposed role for efflux transporters in the pathogenesis of hydrocephalusRole of ATP-binding cassette and solute carrier transporters in erlotinib CNS penetration and intracellular accumulation.Competitive inhibition of organic anion transporting polypeptide 1c1-mediated thyroxine transport by the fenamate class of nonsteroidal antiinflammatory drugsActivation of descending pain-facilitatory pathways from the rostral ventromedial medulla by cholecystokinin elicits release of prostaglandin-E₂ in the spinal cord.In vitro blood-brain barrier models: current and perspective technologiesTargeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.The sensitivity of glioma cells to pyropheophorbide-αmethyl ester-mediated photodynamic therapy is enhanced by inhibiting ABCG2.Targeted drug delivery to treat pain and cerebral hypoxiaDevelopment of new cancer therapeutic agents targeting mitosis.Membrane transporter proteins: a challenge for CNS drug development.The mastermind approach to CNS drug therapy: translational prediction of human brain distribution, target site kinetics, and therapeutic effects.Transporter-mediated uptake into cellular compartments.On the rate and extent of drug delivery to the brain.Microdialysis study of cefotaxime cerebral distribution in patients with acute brain injury.Influence of the G2677T/C3435T haplotype of MDR1 on P-glycoprotein trafficking and ibutilide-induced block of HERG.Proteomic analysis of cerebrospinal fluid in pneumococcal meningitis reveals potential biomarkers associated with survival.Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis.Drug interactions at the blood-brain barrier: fact or fantasy?The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research.Nature and consequences of mammalian brain and CSF efflux transporters: four decades of progress.Virus-induced transcriptional changes in the brain include the differential expression of genes associated with interferon, apoptosis, interleukin 17 receptor A, and glutamate signaling as well as flavivirus-specific upregulation of tRNA synthetasesPost-acute brain injury urinary signature: a new resource for molecular diagnostics.A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers.ATP-binding cassette transporters and their roles in protecting the brain.How much do antiretroviral drugs penetrate into the central nervous system?Prenatal exposure to common environmental factors affects brain lipids and increases risk of developing autism spectrum disorders.Effect of Disease Pathologies on Transporter Expression and Function.
P2860
Q26752962-C38CAD2D-F165-460B-A0AF-B820B15E375FQ26864317-21854D15-F041-4F96-ACC8-E4CE2085F6D7Q27690256-9E6A1CBB-9B1A-4496-A0A5-7165EE7F7B38Q28081947-52A76040-DBBB-4CE1-AC01-A122426C6D55Q28083620-903D452F-14D3-414B-B180-F32DFCCD4DCEQ28088708-D9009056-097B-427F-941C-4A019CA8DEE8Q30361123-D15EB394-E208-40E9-A9FA-8FE510E32A99Q30831016-1A3B0A21-1DC3-4837-A908-085BE1EEB4FCQ33466591-EE758F64-5B4D-45C4-B713-7111DBEF9D3DQ33567329-B44BDB6E-76E1-4002-9CAC-273EDB4E7AA6Q33893813-3E50D8AD-A2D8-40F2-9CEE-B18E503105DDQ33995372-C59E72EF-D4B4-4E58-8D31-4FBE1D5C97FEQ34147836-09164497-3EC7-4D09-BC18-5BA7B1DE71C9Q34472367-27BE8CA5-FF67-4BCE-8D52-183B51E12A22Q34598205-921BA63C-79A2-4FDC-8D8A-6723E40FEA11Q35633022-1209637F-A212-4373-9AE2-7E31FD7754FDQ35782792-AE8550AE-BDCE-47C4-9824-39B62C8A4B77Q35855634-88267EF5-E995-46F1-B9CA-BB6F66B0924FQ36332448-5F217601-DFEC-4B0A-8DB1-D44D9A8D994CQ36591611-2E38D301-094E-4E3D-B83C-E8F4C52C4433Q36623076-95AE6E18-D696-4475-B227-C91E08578F84Q36659167-FE80D9C9-0E09-40F4-BED4-956E3E770393Q36697929-C1600FB7-3745-4005-A6C2-96541789E3EAQ36985076-91DFB773-8D81-42C2-B65B-29FA3E419AD5Q37023904-F1ED3DBE-3CCE-455B-B206-905CADE6CD9BQ37026552-6FE4AE33-B3CB-4C2B-8BC7-3C4285E0107DQ37178631-82982AA5-27CA-4969-8080-10168EAF81EFQ37248844-5D725437-6967-4FE6-BD2E-82757C579B94Q37308322-06CD0583-2F66-4272-B112-8893960E7440Q37314370-1B7DD204-757D-47E9-923B-45649B4AF5ADQ37362486-71164BF8-7522-4C23-9EE5-0589ACCEACCEQ37379470-B817C3E7-BE7D-4A59-84F5-0E24E0EE0359Q37622484-0CEC7C25-C108-4E4A-B795-7D03A55FA8EAQ37634452-03675A56-9051-41D9-A844-A3511E833329Q37667700-EB70CF66-0403-4002-B0A7-518850B074CAQ37798553-161F0F23-3238-40CA-A9D0-76C71F2CF6C4Q37868835-4D5763CE-4833-47B5-A556-16B3F2A20E84Q38003612-116CB0E8-05AE-4BD0-AD3A-2B0BA3AA94ABQ38555255-5CBD2F59-7557-4337-80A6-FE6BD4E60581Q38888360-52A55834-65FF-46E6-A052-59E8F7373069
P2860
Active efflux across the blood-brain barrier: role of the solute carrier family.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Active efflux across the blood-brain barrier: role of the solute carrier family.
@ast
Active efflux across the blood-brain barrier: role of the solute carrier family.
@en
Active efflux across the blood-brain barrier: role of the solute carrier family.
@nl
type
label
Active efflux across the blood-brain barrier: role of the solute carrier family.
@ast
Active efflux across the blood-brain barrier: role of the solute carrier family.
@en
Active efflux across the blood-brain barrier: role of the solute carrier family.
@nl
prefLabel
Active efflux across the blood-brain barrier: role of the solute carrier family.
@ast
Active efflux across the blood-brain barrier: role of the solute carrier family.
@en
Active efflux across the blood-brain barrier: role of the solute carrier family.
@nl
P2860
P356
P1433
P1476
Active efflux across the blood-brain barrier: role of the solute carrier family.
@en
P2093
Hiroyuki Kusuhara
Yuichi Sugiyama
P2860
P356
10.1602/NEURORX.2.1.73
P577
2005-01-01T00:00:00Z